Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ido Rippin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cells|February 12, 2021
Mechanisms and Therapeutic Implications of GSK-3 in Treating NeurodegenerationIdo Rippin, Hagit Eldar-Finkelman
Cells|May 28, 2022
Prospects in GSK-3 Signaling: From Cellular Regulation to Disease TherapySara Arciniegas Ruiz, Ido Rippin, Hagit Eldar-Finkelman
Frontiers in Physiology|May 16, 2022
GSK-3β Inhibition in Birds Affects Social Behavior and Increases Motor ActivityStan Moaraf, Ido Rippin, Joseph Terkel, et al.
Biology|September 23, 2022
Modulating Gene Expression within a Microbiome Based on Computational ModelsLiyam Chitayat Levi, Ido Rippin, Moran Ben Tulila, et al.
Neurobiology of Disease|March 23, 2021
Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's diseaseIdo Rippin, Katherina Bonder, Shirley Joseph, et al.
Plos Biology|February 14, 2024
Correction: Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis processAmnon Wittenstein, Michal Caspi, Ido Rippin, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 26, 2024
Small molecule modulation of p75<sup>NTR</sup> engages the autophagy-lysosomal pathway and reduces huntingtin aggregates in cellular and mouse models of Huntington's diseaseDanielle A Simmons, Namitha Alexander, Gloria Cao, et al.
Plos Biology|November 9, 2023
Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis processAmnon Wittenstein, Michal Caspi, Ido Rippin, et al.
International Journal of Molecular Sciences|November 21, 2020
Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding SiteIdo Rippin, Netaly Khazanov, Shirley Ben Joseph, et al.
The Journal of Investigative Dermatology|May 26, 2023
Ataxia Telangiectasia Mutated Signaling Delays Skin Pigmentation upon UV Exposure by Mediating MITF Function toward DNA Repair ModeNadav Elkoshi, Shivang Parikh, Hagar Malcov-Brog, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cells|February 12, 2021
Mechanisms and Therapeutic Implications of GSK-3 in Treating NeurodegenerationIdo Rippin, Hagit Eldar-Finkelman
Cells|May 28, 2022
Prospects in GSK-3 Signaling: From Cellular Regulation to Disease TherapySara Arciniegas Ruiz, Ido Rippin, Hagit Eldar-Finkelman
Frontiers in Physiology|May 16, 2022
GSK-3β Inhibition in Birds Affects Social Behavior and Increases Motor ActivityStan Moaraf, Ido Rippin, Joseph Terkel, et al.
Biology|September 23, 2022
Modulating Gene Expression within a Microbiome Based on Computational ModelsLiyam Chitayat Levi, Ido Rippin, Moran Ben Tulila, et al.
Neurobiology of Disease|March 23, 2021
Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's diseaseIdo Rippin, Katherina Bonder, Shirley Joseph, et al.
Plos Biology|February 14, 2024
Correction: Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis processAmnon Wittenstein, Michal Caspi, Ido Rippin, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 26, 2024
Small molecule modulation of p75<sup>NTR</sup> engages the autophagy-lysosomal pathway and reduces huntingtin aggregates in cellular and mouse models of Huntington's diseaseDanielle A Simmons, Namitha Alexander, Gloria Cao, et al.
Plos Biology|November 9, 2023
Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis processAmnon Wittenstein, Michal Caspi, Ido Rippin, et al.
International Journal of Molecular Sciences|November 21, 2020
Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding SiteIdo Rippin, Netaly Khazanov, Shirley Ben Joseph, et al.
The Journal of Investigative Dermatology|May 26, 2023
Ataxia Telangiectasia Mutated Signaling Delays Skin Pigmentation upon UV Exposure by Mediating MITF Function toward DNA Repair ModeNadav Elkoshi, Shivang Parikh, Hagar Malcov-Brog, et al.
Pageof 1